Association of plasma free amino acids with hyperuricemia in relation to diabetes mellitus, dyslipidemia, hypertension and metabolic syndrome

被引:20
|
作者
Mahbub, M. H. [1 ]
Yamaguchi, Natsu [1 ]
Takahashi, Hidekazu [1 ]
Hase, Ryosuke [1 ]
Ishimaru, Yasutaka [1 ]
Sunagawa, Hiroshi [1 ]
Amano, Hiroki [2 ]
Kobayashi-Miura, Mikiko [3 ]
Kanda, Hideyuki [4 ]
Fujita, Yasuyuki [4 ]
Yamamoto, Hiroshi [5 ]
Yamamoto, Mai [5 ]
Kikuchi, Shinya [5 ]
Ikeda, Atsuko [6 ]
Kageyama, Naoko [6 ]
Nakamura, Mina [5 ]
Tanabe, Tsuyoshi [1 ]
机构
[1] Yamaguchi Univ, Grad Sch Med, Dept Publ Hlth & Prevent Med, Ube, Yamaguchi, Japan
[2] Tottori Univ, Grad Sch Med, Div Hlth Adm & Promot, Yonago, Tottori, Japan
[3] Shimane Univ, Dept Biochem, Fac Med, Izumo, Shimane, Japan
[4] Shimane Univ, Dept Environm Med & Publ Hlth, Fac Med, Izumo, Shimane, Japan
[5] Ajinomoto Co Inc, Res Inst Biosci Prod & Fine Chem, Kawasaki, Kanagawa, Japan
[6] Ajinomoto Co Inc, Inst Innovat, Kawasaki, Kanagawa, Japan
来源
SCIENTIFIC REPORTS | 2017年 / 7卷
关键词
SERUM URIC-ACID; VISCERAL FAT ACCUMULATION; BRANCHED-CHAIN; INSULIN-RESISTANCE; RISK-FACTOR; BLOOD-PRESSURE; LEVEL; WOMEN; POPULATION; GLYCINE;
D O I
10.1038/s41598-017-17710-6
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Previous studies demonstrated independent contributions of plasma free amino acids (PFAAs) and high uric acid (UA) concentrations to increased risks of lifestyle-related diseases (LSRDs), but the important associations between these factors and LSRDs remain unknown. We quantified PFAAs and UA amongst Japanese subjects without LSRDs (no-LSRD, n = 2805), and with diabetes mellitus (DM, n = 415), dyslipidemia (n = 3207), hypertension (n = 2736) and metabolic syndrome (MetS, n = 717). The concentrations of most amino acids differed significantly between the subjects with and without hyperuricemia (HU) and also between the no-LSRD and LSRD groups (p < 0.05 to 0.001). After adjustment, the logistic regression analyses revealed that lysine in DM, alanine, proline and tyrosine in dyslipidemia, histidine, lysine and ornithine in hypertension, and lysine and tyrosine in MetS demonstrated significant positive associations with HU among the patients with LSRDs only (p < 0.05 to 0.005). By contrast, arginine, asparagine and threonine showed significant inverse associations with HU in the no-LSRD group only (p < 0.05 to 0.01). For the first time, we provide evidence for distinct patterns of association between PFAAs and HU in LSRDs, and postulate the possibility of interplay between PFAAs and UA in their pathophysiology.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Association of plasma free amino acids with hyperuricemia in relation to diabetes mellitus, dyslipidemia, hypertension and metabolic syndrome
    MH Mahbub
    Natsu Yamaguchi
    Hidekazu Takahashi
    Ryosuke Hase
    Yasutaka Ishimaru
    Hiroshi Sunagawa
    Hiroki Amano
    Mikiko Kobayashi-Miura
    Hideyuki Kanda
    Yasuyuki Fujita
    Hiroshi Yamamoto
    Mai Yamamoto
    Shinya Kikuchi
    Atsuko Ikeda
    Naoko Kageyama
    Mina Nakamura
    Tsuyoshi Tanabe
    Scientific Reports, 7
  • [2] Plasma free amino acid profiles evaluate risk of metabolic syndrome, diabetes, dyslipidemia, and hypertension in a large Asian population
    Yamaguchi, Natsu
    Mahbub, M. H.
    Takahashi, Hidekazu
    Hase, Ryosuke
    Ishimaru, Yasutaka
    Sunagawa, Hiroshi
    Amano, Hiroki
    Kobayashi-Miura, Mikiko
    Kanda, Hideyuki
    Fujita, Yasuyuki
    Yamamoto, Hiroshi
    Yamamoto, Mai
    Kikuchi, Shinya
    Ikeda, Atsuko
    Takasu, Mariko
    Kageyama, Naoko
    Nakamura, Mina
    Tanabe, Tsuyoshi
    ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE, 2017, 22 (01)
  • [3] Relationship Between Altered Plasma-Free Amino Acid Levels and Hyperuricemia in Dyslipidemia Without and With Hypertension
    Watanabe, Rie
    Mahbub, M. H.
    Yamaguchi, Natsu
    Hase, Ryosuke
    Wada, Sunao
    Tanabe, Tsuyoshi
    DISEASES, 2024, 12 (11)
  • [4] Plasma Free Amino Acid Profiles Predict Four-Year Risk of Developing Diabetes, Metabolic Syndrome, Dyslipidemia, and Hypertension in Japanese Population
    Yamakado, Minoru
    Nagao, Kenji
    Imaizumi, Akira
    Tani, Mizuki
    Toda, Akiko
    Tanaka, Takayuki
    Jinzu, Hiroko
    Miyano, Hiroshi
    Yamamoto, Hiroshi
    Daimon, Takashi
    Horimoto, Katsuhisa
    Ishizaka, Yuko
    SCIENTIFIC REPORTS, 2015, 5
  • [5] Plasma Free Amino Acid Profiles Predict Four-Year Risk of Developing Diabetes, Metabolic Syndrome, Dyslipidemia and Hypertension in Japanese Population
    Minoru Yamakado
    Kenji Nagao
    Akira Imaizumi
    Mizuki Tani
    Akiko Toda
    Takayuki Tanaka
    Hiroko Jinzu
    Hiroshi Miyano
    Hiroshi Yamamoto
    Takashi Daimon
    Katsuhisa Horimoto
    Yuko Ishizaka
    Scientific Reports, 5
  • [6] Association between dyslipidemia and plasma levels of branched-chain amino acids in the Japanese population without diabetes mellitus
    Fukushima, Keiko
    Harada, Sei
    Takeuchi, Ayano
    Kurihara, Ayako
    Iida, Miho
    Fukai, Kota
    Kuwabara, Kazuyo
    Kato, Suzuka
    Matsumoto, Minako
    Hirata, Aya
    Akiyama, Miki
    Tomita, Masaru
    Hirayama, Akiyoshi
    Sato, Asako
    Suzuki, Chizuru
    Sugimoto, Masahiro
    Soga, Tomoyoshi
    Sugiyama, Daisuke
    Okamura, Tomonori
    Takebayashi, Toru
    JOURNAL OF CLINICAL LIPIDOLOGY, 2019, 13 (06) : 932 - 939
  • [7] Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus
    Brunzell, JD
    Ayyobi, AF
    AMERICAN JOURNAL OF MEDICINE, 2003, 115 : 24 - 28
  • [8] Therapeutic approaches to dyslipidemia in diabetes mellitus and metabolic syndrome
    Cottrell, DA
    Marshall, BJ
    Falko, JM
    CURRENT OPINION IN CARDIOLOGY, 2003, 18 (04) : 301 - 308
  • [9] A Review of COVID-19 in Relation to Metabolic Syndrome: Obesity, Hypertension, Diabetes, and Dyslipidemia
    Makhoul, Elias
    Aklinski, Joseph L.
    Miller, Jesse
    Leonard, Cara
    Backer, Sean
    Kahar, Payal
    Parmar, Mayur S.
    Khanna, Deepesh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (07)
  • [10] Hyperuricemia, Type 2 Diabetes Mellitus, and Hypertension: an Emerging Association
    Ibrahim Mortada
    Current Hypertension Reports, 2017, 19